Treatment.Com International, Inc. (TSE:TRUE) has released an update.
Treatment.com AI Inc. has received funding from the National Institute of Health to develop an AI that gathers family medical history in ways that are culturally sensitive, particularly for African-American families. The project, in partnership with Rush River Research, aims to address health disparities caused by systemic bias and historical trauma by improving how such data is collected and integrated. This effort is part of their broader initiative to create an equitable Global Library of Medicine, with further development and commercialization plans underway.
For further insights into TSE:TRUE stock, check out TipRanks’ Stock Analysis page.
